Specific Inhibitor of Matrix Metalloproteinase Decreases Tumor Invasiveness After Radiofrequency Ablation in Liver Tumor Animal Model

OBJECTIVE: To determine whether the specific inhibitor of matrix metalloproteinase (MMP)—batimastat (BB-94)—could decrease the progression of liver tumor after radiofrequency ablation (RFA) and achieve better therapeutic efficacy in an animal model. METHODS: In vitro experiments, the proliferation o...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, An-Na, Liu, Jing-Tao, Zhao, Kun, Wu, Hao, Wang, Song, Yan, Kun, Yang, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7709861/
https://www.ncbi.nlm.nih.gov/pubmed/33330030
http://dx.doi.org/10.3389/fonc.2020.561805

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7709861/
https://www.ncbi.nlm.nih.gov/pubmed/33330030
http://dx.doi.org/10.3389/fonc.2020.561805

Ejemplares similares